The DNA Microarray Facility provides access to various forms of technology for gene expression analysis, pairticularly DNA microarray technologies, to members ofthe Duke Comprehensive Caricer Institute. This includes Affymetrix microarrays as well as printed DNA microarrays produced in the facility. Importantly, the facility also provides service for microarray analysis, either with Affymetrix arrays or printed oligonucleotide arrays. As a result of the volume of use, the facility has negotiated an agreement with Affymetrix that now provides a very substantial discount in cost of microarrays and services, to the benefit of Cancer Institute members. Beyond the microarray services, the facility also provides Cancer Institute members access to an ABI 7900 RT-PCR instrument for validafion of gene expression results as well as alternative methods of expression assay, and access to an Axon Genepix Scanner for those wanting to scan their own arrays. In addifion, the facility provides substantial support for data analysis and management of microarray datasets. These services include inifial consultafion in experimental design, assessment of RNA quality, generafion of probes, hybridization to arrays, scanning of arrays, data analysis, and data management and storage. The Microarray Core Facility developed and uses a custom LIMS that integrates every point ofthe data production process, starting with sample submissions from researchers to laboratory operations, and then to final billing and posfings. With the LIMS tools and the repository features ofthe Express data repository, data of different types can be grouped and managed by projects, and because ofthe simplicity ofthe web-based interfaces that have been developed, researchers can execute their own analysis and data management in a simplified fashion. The impact of the facility on research in the Cancer Institute has been substantial, as evidenced by the large number of publications as well as the translation of these services into clinical practice in the form of multiple investigator-initiated clinical trials making use of DNA microarray analysis to guide clinical decisions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-40
Application #
8601837
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
40
Fiscal Year
2014
Total Cost
$166,923
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Galaz-Montoya, Monica; Wright, Sara J; Rodriguez, Gustavo J et al. (2017) ?2-Adrenergic receptor activation mobilizes intracellular calcium via a non-canonical cAMP-independent signaling pathway. J Biol Chem 292:9967-9974
Lanier, Megan L; Park, Hyeri; Mukherjee, Paramita et al. (2017) Formal Synthesis of (+)-Laurencin by Gold(I)-Catalyzed Intramolecular Dehydrative Alkoxylation. Chemistry 23:7180-7184
Shi, Qiong; Liu, Hongliang; Han, Peng et al. (2017) Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. J Invest Dermatol 137:1749-1756
Woyach, Jennifer A; Ruppert, Amy S; Guinn, Daphne et al. (2017) BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia. J Clin Oncol 35:1437-1443
Wang, Yanru; Freedman, Jennifer A; Liu, Hongliang et al. (2017) Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Int J Cancer 141:731-743
Fayanju, Oluwadamilola M; Hall, Carolyn S; Bauldry, Jessica Bowman et al. (2017) Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer. Am J Surg 214:666-671
Leu, David; Spasojevic, Ivan; Nguyen, Huy et al. (2017) CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP5. Redox Biol 12:864-871
Sauer, Scott J; Tarpley, Michael; Shah, Imran et al. (2017) Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells. Carcinogenesis 38:252-260
Pan, Yongchu; Liu, Hongliang; Wang, Yanru et al. (2017) Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep 7:44634
Yin, Jieyun; Liu, Hongliang; Liu, Zhensheng et al. (2017) Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol Carcinog 56:1663-1672

Showing the most recent 10 out of 480 publications